Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2026 Jul 28;17:1936586. doi: 10.3389/fphar.2026.1936586

Correction: Single-cell dissection and multi-cohort validation identify a hypoxia-related prognostic signature with experimental verification in lung adenocarcinoma

Fan Zhang 1, Junyan Wang 1, Yu Xu 1, Minting Ma 1, Suju Wei 1, Chengyuan Liu 2,*
PMCID: PMC13458258  PMID: 42582584

An incorrect Funding statement was provided. The correct funding statement reads:

The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the Scientific Research Fund Project of Hebei Provincial Health Commission (Project Category: Youth Science and Technology Project; Tertiary Discipline: Oncological Diagnostics, Approval No. 20190763).

The original version of this article has been updated.

Footnotes

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES